Impact of the systematic use of the Gugging Swallowing Screen in patients with acute ischaemic stroke. (26th October 2018)

• Record Type: Journal Article
• Authors: Lopes, M.; Freitas, E.; Oliveira, M.; Dantas, E.; Azevedo, N.; Rodrigues, P.; Pinho, J.; Ferreira, C.
• Is Part Of: European journal of neurology. Volume 26:Number 5(2019)
• Page Start: 722
• Page End: 726
• Publication Date: 2018-10-26
• Subjects: dysphagia -- ischaemic stroke -- pneumonia -- screening; Neurology -- Periodicals; Nervous system -- Diseases -- Periodicals; 616.8
• DOI: 10.1111/ene.13825
• Languages: English
• ISSNs: 1351-5101

Abstract

Abstract : Background and purpose: Post‐stroke dysphagia occurs in up to three quarters of patients with acute stroke and is associated with a higher risk of respiratory infections and poor outcome. Systematic screening of dysphagia in the acute stroke unit is essential to identify patients at risk of aspiration and to provide dietary recommendations. Our study aimed to assess the impact of the systematic application of the Gugging Swallowing Screen (GUSS) in patients with acute ischaemic stroke. Methods: This was a retrospective study of consecutive patients with acute ischaemic stroke admitted to an acute stroke unit in two time periods: pre‐GUSS (February 2014–July 2015), when the 10‐mL water‐swallowing test was systematically administered, and GUSS (August 2015–October 2016), when the GUSS test was systematically administered. Groups were compared with regard to baseline and stroke characteristics, and the occurrence of stroke‐associated pneumonia (SAP), in‐hospital death and 3‐month outcome. Results: Of the 344 patients who were included in the study (median age 71 years), 51.7% were male with a median National Institutes of Health Stroke Scale score of 11. A total of 204 patients were included during the pre‐GUSS period and 140 during the GUSS period. Patients in the GUSS period more frequently had diabetes and partial anterior circulation syndromes, and were more frequently treated with thrombectomy. There was no difference in the occurrence of SAP between the two groups (pre‐GUSS, 12.5%; GUSS, 15.1%; P = 0.490) and no differences were found concerning in‐hospital mortality ( P = 0.996), 3‐month functional independence ( P = 0.647) or 3‐month mortality ( P = 0.598). Conclusions: The systematic administration of GUSS in a population of patients with acute ischaemic stroke did not reduce the occurrence of SAP, mortality or 3‐month functional dependence when compared with the systematic administration of the 10‐mL water‐swallowing test. Abstract : Click here to view the accompanying paper in this volume.